18th May 2017

Standing on the Shoulders of Giants: Developing Antibiotics

Ex Aula - Logo4-cropped

Hannah Behrens, DPhil Infection, Immunology and Translational Medicine (m.2015)

Although first discovered in 1928, it was only during the Second World War that Penicillin was developed into a drug that could cure people of bacterial diseases. This started the “antibiotic era” and is considered to be one of the most important medical discoveries of the twentieth century. Antibiotics have since been saving us from otherwise fatal bacterial diseases.

Today, nearly a century later, on the same street where penicillin was first mass-produced, another significant step in the development of antimicrobial drugs is taking place: bacteriocins antibiotics.

Over the years, extensive (ab)use of antibiotics led to bacterial resistance. Furthermore, it was found that antibiotics can cause a problem called dysbiosis. Our body contains millions of bacteria, the so-called microbiome. They fulfil many important functions which includes fighting disease-causing bacteria. When an antibiotic kills all these bacteria there is a void that can be filled by the dangerous bacteria, leading to worse diseases than before the treatment (e.g. C. difficile infection).

The onset of dysbiosis is why bacteriocins may be critical to treating bacterial infections. Bacteriocins are very specific antibiotics that kill only one kind of bacteria each, leaving the remaining microbiome intact. They bind to unique molecules on the surfaces of bacteria, trick the bacteria to take them up by disguising themselves as nutrients and finally kill them. Like traditional antibiotics some bacteriocins target transcription and cell wall synthesis, others however poke holes in the bacterium’s membrane or degrade their genetic information, their DNA or RNA.

It is known that bacteriocins are potent antibiotics in mice and pigs (and in moths), more potent in fact than conventional commercial antibiotics. There seem to be very low levels of resistance to bacteriocins and in experiments where bacteria were exposed to bacteriocins repeatedly, resistance did not emerge.

The potential for bacteriocins is huge and the field eagerly anticipates the start of human trials; a significant step forward considering some bacteria are resistant to all 26 antibiotics on the market.[1] One of the things that need to be known about any new medication before it is tested is how it works. This helps anticipate side effects. Therefore, my research focusses on unravelling the mechanism behind the most potent bacteriocin found to date:  pyocin S5.

More specifically, I investigate how is pyocin S5 is so specific in finding its target cells? How does it get into target cells to kill? Where does the energy for the entry come from? And, can bacteria inactivate bacteriocins?

While these are very specific questions, answering them will (hopefully) be the first step to opening up the whole repertoire of bacteriocins for use in patients. If bacteriocins can prevent us from falling back into the pre-antibiotic era, their arrival could be as important as the discovery of penicillin was in Sir Alexander Flemings laboratory, close to a century ago.

[1] Ashley Welch, ‘Woman died from superbug resistant to all available antibiotics in US’, 13 Jan. 2017, CBS News, http://www.cbsnews.com/news/woman-dies-from-superbug-resistant-to-all-available-antibiotic-in-u-s/.

Recent Research Highlights

5th December 2018

Václav JANEČEK: ‘Ownership of Personal Data in the Internet of Things’

Data Protection?

In light of the recent developments in data protection laws around the world, Ex Aula is delighted to present a short video that examines the implications of data protection rights. Aimed at a non-specialist audience, DPhil student Václav Janeček discusses his work (published in the journal ‘Computer Law and Security Review’) on data ownership in the context of EU […]

Read More…

25th March 2018

Caricaturing Terror

How does one draw tragedy? How can terror be depicted without trivialising the sorrow of those who suffered from it? In Pakistan terror is not something one can caricaturise, when the terrorist can be present a few metres from you, ready to detonate a bomb in the centre of your hometown [1]. When you cannot […]

Read More…

11th March 2018

Molecules that make you think: using genetics to understand our emotions

The most common question I’ve been asked when introducing my work to strangers, friends, and Tinder dates has been “but aren’t mental illnesses…in the mind? What do genes or molecules have anything to do with it?” The answer is, in short, everything. Each of our mental functions is fundamentally rooted in biological processes that can […]

Read More…

4th March 2018

Romance Comic Books, the Cold War, and Teaching Women Their Place

I came across romance comic books by accident during a tiring Google search for a topic for a term paper. At first, I thought romance comic books were a joke – that a modern artist had created them to make fun of 1950’s domestic ideals. Then I found out that Captain America creators, Joe Simon […]

Read More…

18th February 2018

Coming Up For Air: 100 Million Years of Ocean Biology

  George Cuvier was a young man at the Storming of the Bastille in the summer of 1789. It was under the shadow of the French Revolution that he developed the concept of ‘catastrophism’. In the midst of the radical political changes that were engulfing Europe, Cuvier speculated that the Earth itself had undergone radical, […]

Read More…